Skip to main content
OpenTrials
Completed

NCT Number: NCT06029855

Kabat Rehabilitation Versus Mime Therapy on Facial Disability and Synkinesis in Patients of Bell's Palsy

Bell's palsy, also called idiopathic facial paralysis, is a common cause of unilateral facial paralysis. It is one of the most common neurological disorders of the cranial nerves.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The University of Lahore

Lahore, Punjab Province, 5400, Pakistan

About this study

Bell's palsy is an alarming condition of rapid onset, which paralyzes half of the facial muscles. Kabat rehabilitation is a manual resistance technique that promotes a basic pattern of movement through facilitation, inhibition, and resistance of a group of muscles. It increases the functioning and power of facial muscles while Mime therapy results in immediate improvement of function and integrity of facial muscles. It also mitigates synkinesis in Bell's palsy. Both techniques are easy to apply. They are clinically important techniques that are easily understood by patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age group 25-50 years.
  • Both male and female.
  • Unilateral bell's paralysis.
  • Not congenital in origin.
  • Sub-acute and chronic cases.

Exclusion criteria

  • Other neurological deficits include epilepsy and Alzheimer's disease.
  • Traumatic onset.
  • Surgical reconstruction (nerve or muscle reconstruction).
  • Mental and psychological disorders i.e., schizophrenia, bipolar disorders.
  • Skin diseases (eczema, urticarial) as electrical stimulation may affect the results.
  • Any contraindications for massage like sunburn, bruising, or cuts.

Treatment and study plan

Kabat Therapy

Other

The participants of group A will receive Kabat Rehabilitation with routine physical therapy. The protocol will be given to the participants for three sessions/week for six weeks. Each session will be of 30 minutes.

MIME THERAPY

Other

The participants of group B will receive Mime Therapy in addition to routine physical therapy. The protocol will be given to the participants once a week for six weeks, while physical therapy will be given on alternate days. Each session will be of 30 minutes.

Primary outcomes

  1. Change in Synkinesis

    Time frame: It will be assessed at baseline, at the third week and at six week.

    Synkinesis will be accessed through the "House-Brackmann Scale". It is classified as a universal scale. This scale analyses the symmetry, synkinesis, stiffness, and global mobility of the face. It is divided into six categories (normal, mild dysfunction, moderate dysfunction, moderately severe dysfunction, severe dysfunction, and total paralysis) and is a 0-6-point scale with 6 representing total paralysis.

  2. Level of Facial Disability

    Time frame: Change in functional status will be measured at the baseline, at 3rd week and at 6th week.

    The level of Facial disability will be measured through the "Facial Disability Index Scale". This scale has ten items that evaluate the patient's physical and social aspects (mastication, deglutition, communication, labial mobility, emotional alterations, and social integration). It uses a hundred-point scale with a higher score indicating less impairment. 24 Minimum score for physical functioning: 0, Maximum score for physical functioning: 25, Minimum score for social and well-being: 5, Maximum score for social and well-being.

Sponsors and collaborators

Lead sponsor

University of Lahore

Other

Registry information

Official study title

Effects Of Kabat Rehabilitation Versus Mime Therapy On Facial Disability And Synkinesis In Patients Of Bell's Palsy

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Sep 8, 2023
Registry last updated
Mar 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.